Article ID Journal Published Year Pages File Type
8623022 Scandinavian Journal of Pain 2017 8 Pages PDF
Abstract
Vapocoolant spray significantly decreased peripheral intravenous cannulation pain in adults versus placebo spray and was well tolerated with minor adverse effects that resolved quickly. There were no significant differences in vital signs and no visible skin changes documented by photographs taken within 5-10 min postspray/PIV.
Related Topics
Health Sciences Medicine and Dentistry Anesthesiology and Pain Medicine
Authors
,